Aequus Provides Update and Reports Third Quarter 2024 Financial Highlights.
VANCOUVER, November 12, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing, and promoting...
Read More